Comment on "Integrative multi-omics profiling identifies infiltrative hepatocellular carcinoma as an immunotherapy-resistant subtype with distinct molecular features"
Clinical and Molecular Hepatology · 29.10.2026
DOI: 10.3350/cmh.2026.0141 ↗Kurz gefasst
Kommentar in der Zeitschrift Clinical and Molecular Hepatology, online erschienen am 29.10.2026. Verfasst von Mulin Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, First Affiliated Hospital of Dalian Medical University, Dalian, 116011, Liaoning, China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory, First Affiliated Hospital of Dalian Medical University, Dalian, 116011, Liaoning, China.
- Department of Biochemistry and Molecular Biology, Liaoning Provincial Core Lab of Glycobiology and Glycoengineering, College of Basic Medical Sciences, Dalian Medical University, Dalian, 116044, Liaoning, China. zhengqi…
- Department of Nephrology, First Affiliated Hospital of Dalian Medical University, Dalian, 116011, Liaoning, China. shennan@dmu.edu.cn.
Zitieren
APA
Liu, M., Zheng, Q., & Shen, N. (2026). Comment on "Integrative multi-omics profiling identifies infiltrative hepatocellular carcinoma as an immunotherapy-resistant subtype with distinct molecular features". Clinical and Molecular Hepatology. https://doi.org/10.3350/cmh.2026.0141
Vancouver
Liu M, Zheng Q, Shen N. Comment on "Integrative multi-omics profiling identifies infiltrative hepatocellular carcinoma as an immunotherapy-resistant subtype with distinct molecular features". Clinical and Molecular Hepatology. 2026. doi:10.3350/cmh.2026.0141
BibTeX
@article{Liu2026,
author = {Liu, Mulin and Zheng, Qin and Shen, Nan},
title = {Comment on "Integrative multi-omics profiling identifies infiltrative hepatocellular carcinoma as an immunotherapy-resistant subtype with distinct molecular features"},
journal = {Clinical and Molecular Hepatology},
year = {2026},
doi = {10.3350/cmh.2026.0141}
}
EUVIMED